Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background Current standard therapies for Helicobacter pylori (H. pylori) are limited by side effects and antibiotic resistance. Evidence suggests that high-dose amoxicillin dual therapy with a proton pump inhibitor offers comparable efficacy with an improved safety profile. Methods This trial substituted the novel acid blocker tegoprazan for a proton pump inhibitor in the dual therapy regimen. We enrolled 400 patients with confirmed H.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.